Kensing Acquires Advanced Organic Materials (AOM)

Kensing (One Rock Portfolio) Acquires Vitae Naturals

June 28, 2022

Manufacturing

Kensing, a One Rock Capital Partners portfolio company, has acquired Vitae Naturals, a Spanish manufacturer of plant sterol esters and non-GMO natural vitamin E derivatives. The acquisition expands Kensing's European footprint and strengthens its food, nutrition and personal care ingredient offerings.

Kensing Acquires Evonik's Hopewell, VA Amphoteric Surfactants and Specialty Esters Operations

November 1, 2022

Manufacturing

Kensing, a One Rock Capital Partners portfolio company, completed the acquisition of Evonik's Hopewell, Virginia amphoteric surfactants and specialty esters manufacturing operations. The add-on expands Kensing's plant-based surfactant and ester product portfolio, strengthening its position in the personal care and home care markets.

One Rock Capital Partners Acquires Kankakee Specialty Chemicals Site from BASF (Kensing)

June 1, 2021

Manufacturing

One Rock Capital Partners' affiliate has completed the acquisition of BASF's Kankakee, Illinois manufacturing site and associated specialty-chemicals businesses and established the standalone company Kensing. The newly independent business, led by CEO Serge Rogasik, employs roughly 160–190 people and produces plant-derived specialty ingredients (phytosterols, natural vitamin E, anionic surfactants and esters) serving personal care, food & nutrition, healthcare and agriculture markets.

Ridgemont Equity Partners Acquires American Outcomes Management

February 24, 2022

Healthcare Services

Ridgemont Equity Partners has acquired American Outcomes Management (AOM), a U.S.-based specialty home infusion provider focused on IVIG therapy. Ridgemont intends to invest in AOM’s team and capabilities to expand its geographic footprint and add additional specialty infusion therapies; financial terms were not disclosed.

Revelstoke Capital Partners Recapitalizes AOM Infusion

April 15, 2025

Healthcare Services

Revelstoke Capital Partners completed a recapitalization of AOM Infusion, a specialty infusion provider that delivers IVIG, biologics and other therapies for chronic conditions. Revelstoke will support AOM's management team to expand therapeutic focus areas, deepen clinical expertise and grow the company's patient reach; terms were not disclosed.

Hemptown Organics Acquires Kirkman Group Nutraceutical Manufacturing Assets

July 10, 2019

Manufacturing

Hemptown Organics Corp (Hemptown USA) acquired substantially all assets of the Kirkman Group, an FDA-licensed, cGMP-certified nutraceutical manufacturing business based in Lake Oswego, Oregon. The deal provides Hemptown a 25,000 sq. ft. manufacturing facility, formulations, production equipment, and the Kirkman management team and IP, accelerating Hemptown's vertical integration and entry into consumer packaged goods.